CPRX FY 2015 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$34,468

Operating Income

-$20M

Net Income

-$20M

EPS (Diluted)

$-0.25

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$60M

Total Liabilities

$5M

Stockholders' Equity

$55M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$34,468	$0	—
Operating Income	-$20M	-$15M	-39.8%
Net Income	-$20M	-$16M	-30.5%